AGPS anticorps (AA 31-130) (Cy7)
Aperçu rapide pour AGPS anticorps (AA 31-130) (Cy7) (ABIN1708856)
Antigène
Voir toutes AGPS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 31-130
-
Réactivité croisée
- Rat
-
Homologie
- Human,Mouse,Cow,Pig,Horse
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human AGPS/Alkyl-DHAP synthase
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- AGPS (Alkylglycerone Phosphate Synthase (AGPS))
-
Autre désignation
- AGPS/Alkyl-DHAP synthase
-
Sujet
-
Synonyms: AAG5, ADAP-S, ADAS, ADAS_HUMAN, ADHAPS, ADPS, Aging associated gene 5 protein, Aging-associated gene 5 protein, AGPS, ALDHPSY, Alkyl-DHAP synthase, Alkyldihydroxyacetonephosphate synthase, Alkyldihydroxyacetonephosphate synthase, peroxisomal, Alkylglycerone phosphate synthase, Alkylglycerone-phosphate synthase, peroxisomal.
Background: AGPS is a 658 amino acid enzyme that is required for glycerolipid metabolism and ether lipid biosynthesis. Localized to the inner aspect of the peroxisomal membrane, AGPS is likely part of a heterotrimeric complex that is also composed of GNPAT and a modified form of GNPAT. Containing one FAD-binding PCMH-type domain, AGPS utilizes FAD as a cofactor in the synthesis of alkyl-glycerone 3-phophate and a long-chain acid anion from 1-acteyl-glyerone 3-phosphate and a long-chain alcohol. Defects in the gene encoding AGPS results in rhizomelic chondrodysplasia punctata type 3, a disease characterized by vertebral disorders, severe mental retardation, cutaneous lesions, cataracts and rhizomelic shortening of the humerus and femur.
-
ID gène
- 8540
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-